Dawn C. Bir
Overview
Dawn C. Bir received an average of $3M in total compensation, including $406K in salary, at REATA PHARMACEUTICALS from 2019 to 2021.
Source: SEC filings on April 29, 2022, April 30, 2021, and April 29, 2020.
Related executives
We found six more executives who work or worked at REATA PHARMACEUTICALS.
J Huff
REATA PHARMACEUTICALS
Chief Executive Officer
Manmeet Soni
REATA PHARMACEUTICALS
Chief Financial Officer
Colin Meyer
REATA PHARMACEUTICALS
Chief Innovation Officer and Executive Vice President
Michael Wortley
REATA PHARMACEUTICALS
Chief Legal Officer
Jason Wilson
REATA PHARMACEUTICALS
Executive Vice President, Operations
Keith Ward
REATA PHARMACEUTICALS